A Prospective, Descriptive, Quality Improvement Study to Decrease Incontinence-Associated Dermatitis and Hospital-Acquired XXXX .

@entity1 @entity6227 @entity532 @entity322
UNASSIGNED: Incontinence is a common problem among hospitalized @entity1 and has been associated with @entity532 , including @entity322 ( @entity322 ) and @entity6227 ( @entity6227 ). A prospective, descriptive study was conducted in 2 acute care neurology units to 1) assess the prevalence of @entity322 and incidence of @entity322 and @entity6227 among incontinent @entity1 , and 2) evaluate the effect of caregiver education and use of a 1-step cleanser, moisturizer, barrier product on the development of @entity322 and @entity6227 among @entity1 with @entity322 . During a period of 1 month, the @entity322 status of admitted @entity1 was recorded and skin was assessed for the presence/absence of @entity322 and @entity6227 twice per day. After the 1-month data collection, all clinicians on the study units completed a facility-based online education program about @entity322 , @entity6227 , and skin care followed by the implementation of a 1-step cleanser/barrier product for skin care of all @entity1 with @entity322 . Data collection procedures remained the same. Data were collected using a paper/pencil instrument and entered into a spreadsheet for analysis. Descriptive statistics were calculated and prevalence and incidence rates were compared between the pre-intervention and post-intervention phase using Fisher's exact analysis. During the first phase of the study, 17 of 40 admitted @entity1 (42.5%) were incontinent. Of those, 5 (29.4%) developed @entity322 and all of these @entity1 developed @entity6227 (5 of 40 admitted, 29.4%) during an average length of stay of 7.3 (range: 2-14) days. In the intervention phase of the study, 25 of 46 (54.3%) @entity1 were incontinent and none developed @entity322 or a HAPU during an average length of stay of 7.4 (range: 2-14) days. The average Braden scale score was 14.14 in the pre-intervention group of @entity1 with @entity322 and 12.74 in the intervention group. The prevalence of @entity322 among @entity1 admitted to acute care neurology units and the rate of @entity322 in these populations is high. After educating clinicians and implementing @entity322 care procedures with a 1-step product, the rate of @entity6227 decreased significantly but the rate of IADs remained the same. Clinicians should consider the results of this and other studies when developing @entity322 -care protocols. Controlled clinical studies utilizing more detailed @entity322 assessments will help elucidate these observations.
